Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
This report contains market size and forecasts of Gastrointestinal in Global, including the following market information:
Global Gastrointestinal Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Gastrointestinal market was valued at 35710 million in 2021 and is projected to reach US$ 44400 million by 2028, at a CAGR of 3.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prescription Gastrointestinal Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gastrointestinal include AstraZenec, Sanofi, Bayer, Pfizer, GlaxoSmithKline, Teva, Zeria（Tillotts）, Perrigo and Boehringer Ingelheim, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gastrointestinal companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastrointestinal Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Gastrointestinal Market Segment Percentages, by Type, 2021 (%)
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Global Gastrointestinal Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Gastrointestinal Market Segment Percentages, by Application, 2021 (%)
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Others
Global Gastrointestinal Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Gastrointestinal Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastrointestinal revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Gastrointestinal revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZenec
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria（Tillotts）
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen